Alpha Mark Advisors, LLC Aligos Therapeutics In Transaction History
Alpha Mark Advisors, LLC
- $231 Million
- Q4 2024
Number of Shares
1,100
Previous 100
1000.0%
Holding current value
$44,000
Previous $1,000
4300.0%
% of portfolio
0.02%
Previous 0.0%